For which conditions can PlasmaClear be considered?
PlasmaClear is an advanced plasma modification therapy designed to reduce harmful circulating substances, optimize the body's internal environment, and support natural repair and regeneration processes. By removing inflammatory proteins, autoantibodies, cellular debris, misfolded proteins, toxins, and other unwanted biological factors, PlasmaClear may help support patients facing a variety of chronic, degenerative, inflammatory, and neurological conditions.
Every patient is different. PlasmaClear is not a diagnosis-specific treatment but rather a personalized therapy that aims to improve the biological environment in which cells, tissues, and organs function.
Cognitive health and brain function
Many neurological and age-related cognitive conditions are associated with chronic inflammation, protein accumulation, impaired circulation, and cellular dysfunction. PlasmaClear may be considered as part of a comprehensive care strategy for:
Alzheimer's disease
Supporting brain health by reducing harmful circulating factors associated with neurodegeneration. Clinical plasma exchange studies have demonstrated promising results in slowing cognitive decline in selected patients.
Dementia
For individuals experiencing progressive cognitive impairment and loss of daily functioning.
Mild cognitive impairment (MCI)
Supporting patients who notice early memory changes, reduced concentration, or declining executive function.
Memory loss
Helping optimize the biological environment that supports healthy brain function and cellular communication.
Cognitive decline
For individuals seeking proactive intervention before more advanced neurological deterioration develops.
Autoimmune and inflammatory disorders
Many autoimmune diseases involve abnormal antibodies, immune complexes, and inflammatory mediators circulating in the bloodstream. PlasmaClear may help reduce this burden and support immune system regulation.
Conditions that may be considered include:
Autoimmune diseases
A broad category of disorders where the immune system mistakenly attacks healthy tissues.
Rheumatologic conditions
Inflammatory disorders affecting joints, connective tissues, muscles, and organs.
Myasthenia gravis
An autoimmune neuromuscular disorder that affects muscle strength and communication between nerves and muscles.
Guillain-Barré syndrome
A neurological autoimmune condition affecting the peripheral nervous system.
Chronic inflammatory demyelinating polyneuropathy (CIDP)
A chronic neurological disorder characterized by progressive nerve damage and weakness.
Long COVID and post-viral syndromes
Persistent inflammation, immune dysregulation, abnormal clotting, and circulating inflammatory factors are increasingly recognized in patients suffering from Long COVID. Patients may experience:
- Chronic fatigue
- Brain fog
- Memory problems
- Reduced exercise tolerance
- Neurological symptoms
- Persistent inflammation
PlasmaClear may be considered as part of an individualized recovery strategy aimed at reducing biological burden and improving functional recovery.
Circulatory and blood disorders
Some medical conditions involve abnormal plasma composition or excessive circulating proteins that affect blood flow and tissue oxygenation.
Hyperviscosity syndrome
Conditions where blood becomes abnormally thick, impairing circulation and increasing strain on organs and tissues.
Hypergammaglobulinemia-related hyperviscosity
Elevated protein levels in the blood that may contribute to circulatory dysfunction.
Thrombotic thrombocytopenic purpura (TTP)
A serious disorder involving abnormal clot formation within small blood vessels.
Wilson's disease
A rare genetic disorder involving abnormal copper accumulation. Plasma-based therapies may play a role in selected cases.
Hypercholesterolemia syndrome
A condition involving abnormally high cholesterol levels in the blood.
Healthy aging and longevity
As we age, the bloodstream accumulates inflammatory proteins, oxidized molecules, cellular debris, and other factors that may contribute to biological aging and declining function. PlasmaClear was developed around the concept of optimizing the body's "cellular habitat" by improving the quality of the plasma environment that supports every cell in the body.
Individuals interested in:
- Healthy aging
- Cognitive preservation
- Performance optimization
- Enhanced recovery
- Preventive health strategies
- Longevity medicine
may consider PlasmaClear as part of a physician-guided health optimization program.
Symptoms patients commonly seek help for
Many patients do not initially seek treatment because of a diagnosis, but because of persistent symptoms that affect quality of life.
PlasmaClear patients commonly report concerns such as:
- Brain fog
- Memory problems
- Mental fatigue
- Physical fatigue
- Chronic inflammation
- Reduced exercise recovery
- Low energy
- Chronic pain
- Sleep disturbances
- Reduced resilience
- Age-related decline
Patients in the PlasmaClear program have reported improvements in energy, mood, sleep, pain levels, recovery, mental clarity, speech, and problem-solving abilities following treatment, although individual results vary.
A personalized approach
Not every patient is a candidate for PlasmaClear. Every individual undergoes a thorough medical evaluation to determine suitability, treatment goals, and the most appropriate protocol.
Because PlasmaClear focuses on improving the body's internal biological environment, it may be considered for many conditions with inflammatory, autoimmune, neurological, degenerative, or age-related components. The conditions listed above are examples and do not represent a complete list of potential applications.
Is PlasmaClear right for you?
The best way to determine whether PlasmaClear may be appropriate for your situation is through a comprehensive consultation with a partner clinic. The clinic evaluates your health history, laboratory findings, symptoms, and goals and discusses a personalized treatment strategy with you.